|
|
|
|
|
|
|
Request your FREE Special Report today and you'll |
Bioscience company Metabolix, Inc. (Nasdaq: MBLX), reported after Tuesday’s close that its fourth-quarter loss narrowed from a year ago, while full year 2007 revenues beat the consensus on Wall Street. Shares gained 19.7%, or $2.47, to $15.00 ahead of the opening bell.
For detailed price information and recent news stories about Metabolix, click MBLX.
Join Daily Profit today and get our unique perspective and investment ideas in your inbox every day.
Please tell us where we can send your free subscription. Plus, as a free gift, I'll rush you a copy of my Top 10 Forever Stocks - a special bonus report.
Wyatt Investment Research
c/o Business Financial Publishing
65 Railroad Street
PO Box 790
Richmond, VT 05477
